STEPHANIE GLENN: Open Payments
NPI 1326745852 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 48 payments from 19 companies in 2025. Trend: 2023 $645 · 2024 $1,279 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $167 |
| Janssen Biotech, Inc. | 8 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| HEARTFLOW, INC. | 2 | $60 |
| Ardelyx, Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Boston Scientific Corporation | 2 | $32 |
Products named: TREMFYA, RINVOQ, ENTYVIO, FFRct, IBSRELA, CAMZYOS, LINZESS, GATTEX.
Industry payments across UT — which companies pay providers there.
